
Theratechnologies THTX
Annual report 2024
added 04-25-2026
Theratechnologies ROA Ratio 2011-2026 | THTX
Annual ROA Ratio Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -26.61 | -22.63 | -423.02 | -4.23 | -24.18 | 0.77 | 3.14 | -32.28 | -16.92 | -38.11 | -34.59 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.14 | -423.02 | -56.24 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
-76.23 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | ||
|
Applied Therapeutics
APLT
|
-218.41 | - | - | $ 8.42 M | ||
|
Aptorum Group Limited
APM
|
-7.29 | $ 0.88 | -2.05 % | $ 6.47 M | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
19.07 | $ 22.46 | 0.72 % | $ 3.72 B | ||
|
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-1008.51 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
26.14 | - | -4.8 % | $ 255 M | ||
|
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | ||
|
Cara Therapeutics
CARA
|
-56.79 | - | -3.03 % | $ 260 M | ||
|
CASI Pharmaceuticals
CASI
|
-26.5 | - | - | $ 35.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
ChromaDex Corporation
CDXC
|
16.34 | - | -0.88 % | $ 598 M | ||
|
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | ||
|
Galectin Therapeutics
GALT
|
-157.87 | $ 2.32 | -2.32 % | $ 148 M | ||
|
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | ||
|
Genmab A/S
GMAB
|
22.5 | $ 26.78 | 0.53 % | $ 16.8 B | ||
|
Aridis Pharmaceuticals
ARDS
|
-206.68 | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
65.02 | $ 100.91 | -1.13 % | $ 27.2 B | ||
|
Checkpoint Therapeutics
CKPT
|
-752.78 | - | - | $ 169 M | ||
|
Avenue Therapeutics
ATXI
|
-99.25 | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-52.23 | $ 4.08 | -0.61 % | $ 436 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 23.06 | -1.54 % | $ 2.93 B | ||
|
Heron Therapeutics
HRTX
|
-7.89 | $ 1.22 | 2.1 % | $ 203 M | ||
|
ImmuCell Corporation
ICCC
|
-2.45 | $ 8.34 | 1.07 % | $ 75.3 M | ||
|
Autolus Therapeutics plc
AUTL
|
-48.81 | $ 1.49 | 4.58 % | $ 397 M | ||
|
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
0.11 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | ||
|
Innate Pharma S.A.
IPHA
|
-19.74 | $ 1.41 | 0.71 % | $ 235 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 2.92 | -0.14 % | $ 4.81 M | ||
|
Inventiva S.A.
IVA
|
-40.69 | $ 5.04 | -1.75 % | $ 138 M | ||
|
BeiGene, Ltd.
BGNE
|
3.5 | - | 0.49 % | $ 251 B | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
bluebird bio
BLUE
|
-34.23 | - | - | $ 546 M |